IMAP is pleased to announce that Degroof Petercam (IMAP Belgium) advised the family shareholders of Group Orthopedie Leunen (“Group Leunen”) on its sale to Groupe Lagarrigue (“Lagarrigue”)
Group Leunen is a leading Belgian provider of custom-made orthopaedic devices for patients suffering from permanent or temporary disability. It has developed top-notch expertise in prostheses, custom-made orthotics, orthopaedic shoes and mobility solutions. With approximately 50 staff, the group operates seven own patient-care centers and is present in over 30 hospitals and medical centers in Belgium.
Groupe Lagarrigue has been recognized as a leading company in the French market and French-speaking part of Switzerland for orthopaedic equipment. It currently employs over 1,000 people in France, Switzerland, Germany, Spain and Canada. Besides its patient care activities (similar activity as Group Leunen), Lagarrigue has developed and commercializes leading CAD/CAM software (Rodin), used by the orthopaedic sector worldwide and has established its own O&P components branch. As a portfolio company of the French PE firm ‘Ardian’, it has experienced strong growth over recent years through M&A.
To reinforce and guarantee the continuity of Group Leunen, the shareholders decided to search for a new partner and through an organized competitive sale process, found the ideal partner in Lagarrigue.
The Degroof Petercam (IMAP Belgium) team, led by Klaas Dams, acted as sole financial advisor to Group Leunen. With the V!GO transaction in November 2019, this is the second consecutive transaction Degroof Petercam has successfully closed in the orthopaedic sector and underlines once more Degroof Petercam’s expertise in the Healthcare sector.